INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![GettyImages-1465073023 oral solid dose]( "Targeted Protein Degraders: Transforming Oral Therapeutics")
Targeted Protein Degraders: Transforming Oral TherapeuticsCDMOs play a critical role in TPD development by offering specialized infrastructure and analytical capabilities to support the transition from preclinical research to clinical supply and commercialization.
-
![Ropack Capabilities]( "Expertise In Solid Oral Dose Contract Manufacturing And Packaging")
Expertise In Solid Oral Dose Contract Manufacturing And PackagingDiscover a solution with nearly 50 years of excellence in solid oral dose manufacturing and packaging that has innovative facilities and skilled professionals to deliver trusted products worldwide.
-
![GettyImages-462287059-computer-motherboard]( "Built Like A Tech Company: Why CROs Need A New Operating System")
Built Like A Tech Company: Why CROs Need A New Operating SystemSee why building digital, automated infrastructure is essential, and better aligns CROs with today's speed, compliance, and innovation needs.
-
![GettyImages-2163190867-hospital-doctor-administrator-discussion]( "Site Management Support To Investigational Sites")
Site Management Support To Investigational SitesRare disease trials demand specialized site support. Explore how tailored site management practices can improve consistency, data quality, and patient engagement in complex clinical studies.
-
Outsourcing Patient Recruitment: What You Need To Know8/18/2025
Sponsors and CROs are increasingly outsourcing patient recruitment to specialized vendors to address the ongoing challenge of meeting initial recruitment targets on time.
-
Successful Implementation Of A Drug-Device Combination Submission11/21/2025
Projects including both drug and device components require strategic planning for smooth initiation. Regulatory considerations are the key to success.
-
Navigating The Unique Attributes Of Psychedelic Drug Development1/22/2024
Join our panel of experts for an in-depth review of the FDA's guidance on psychedelic drug development, exploring necessary methodological adaptations for safety, pharmacology, and efficacy.
-
A Guide To Patient Reimbursements And Payments9/13/2024
Delayed or inadequate payments can harm patient retention and site efficiency. Learn how sponsors can mitigate financial toxicity, streamline reimbursement, and ensure a positive experience for all involved.
-
Biopharma Giant Streamlines Infrastructure With Proprietary Software11/17/2025
Archiving legacy QMS systems into a centralized platform reduced costs, simplified access, and improved efficiency for a global diagnostics company undergoing quality process harmonization.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![GettyImages-1435226184 data]( "APAC Biopharma: Bridge The Gap To The US FDA")
Uncover how these regulatory and partner/outsource services are invaluable for biopharma innovators in navigating the U.S. FDA regulatory process.
-
![Business Merger GettyImages-1215758851]( "Global Consulting Powered By Relevant Experience")
Solve mission critical challenges and bring life-changing therapies to patients faster with Advarra Consulting.
-
![GettyImages-1311977468 site payments]( "Rave Site Payments – The Industry's Only Global Payment Technology Driven By EDC")
Rave Site Payments is a unified, cloud-based technology that makes site payments as easy as payroll. Your accounting department doesn’t skip paychecks or miscalculate wages and taxes, and now your clinical finance team doesn’t have to either.
-
![GettyImages-2036497889-lab-computer-research]( "What Our Portal Does For Sites, Sponsors, And Patients")
Clinical trial portals should reduce friction—not add it. Streamlined tools empower sites, support patients, and give sponsors visibility without micromanagement or unnecessary complexity.
-
![GettyImages-1088537588 disease]( "Liver Disease CRO Services")
Biotechnology companies consider locations in the Asia-Pacific region, such as South Korea and China to access vast treatment-naïve patient populations and accelerate their clinical trials at lower costs.
